These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23838107)

  • 1. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
    Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
    Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
    Iqbal J; Zhang YJ; Holmes DR; Morice MC; Mack MJ; Kappetein AP; Feldman T; Stahle E; Escaned J; Banning AP; Gunn JP; Colombo A; Steyerberg EW; Mohr FW; Serruys PW
    Circulation; 2015 Apr; 131(14):1269-77. PubMed ID: 25847979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
    Mancini GBJ; Hartigan PM; Shaw LJ; Berman DS; Hayes SW; Bates ER; Maron DJ; Teo K; Sedlis SP; Chaitman BR; Weintraub WS; Spertus JA; Kostuk WJ; Dada M; Booth DC; Boden WE
    JACC Cardiovasc Interv; 2014 Feb; 7(2):195-201. PubMed ID: 24440015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.
    Chivardi C; Morgan H; Sculpher MJ; Clayton T; Evans R; Dodd M; Petrie M; Rinaldi CA; O'Kane P; Brown L; Perera D; Saramago P;
    Circ Cardiovasc Qual Outcomes; 2024 Jan; 17(1):e010533. PubMed ID: 37929587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).
    Padala SK; Sidhu MS; Hartigan PM; Maron DJ; Teo KK; Spertus JA; Mancini GB; Sedlis SP; Chaitman BR; Heller GV; Weintraub WS; Boden WE
    Am J Cardiol; 2015 Nov; 116(10):1509-15. PubMed ID: 26410604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
    Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.